- Home
- CC vs PRCT Comparison
CC vs PRCT Comparison
Compare CC & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CC
- PRCT
- Stock Information
- Founded
- CC 2014
- PRCT 2009
- Country
- CC United States
- PRCT United States
- Employees
- CC N/A
- PRCT N/A
- Industry
- CC Major Chemicals
- PRCT Medical Specialities
- Sector
- CC Industrials
- PRCT Health Care
- Exchange
- CC Nasdaq
- PRCT Nasdaq
- Market Cap
- CC 2.9B
- PRCT 2.9B
- IPO Year
- CC N/A
- PRCT 2021
- Fundamental
- Price
- CC $11.36
- PRCT $53.03
- Analyst Decision
- CC Buy
- PRCT Strong Buy
- Analyst Count
- CC 9
- PRCT 7
- Target Price
- CC $22.00
- PRCT $91.43
- AVG Volume (30 Days)
- CC 4.3M
- PRCT 1.0M
- Earning Date
- CC 05-26-2025
- PRCT 04-24-2025
- Dividend Yield
- CC 8.80%
- PRCT N/A
- EPS Growth
- CC N/A
- PRCT N/A
- EPS
- CC 0.57
- PRCT N/A
- Revenue
- CC $5,782,000,000.00
- PRCT $224,498,000.00
- Revenue This Year
- CC $5.02
- PRCT $46.28
- Revenue Next Year
- CC $4.12
- PRCT $32.67
- P/E Ratio
- CC $19.93
- PRCT N/A
- Revenue Growth
- CC N/A
- PRCT 64.84
- 52 Week Low
- CC $9.33
- PRCT $47.04
- 52 Week High
- CC $29.21
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- CC 41.27
- PRCT 42.69
- Support Level
- CC $10.74
- PRCT $51.27
- Resistance Level
- CC $11.70
- PRCT $54.75
- Average True Range (ATR)
- CC 0.98
- PRCT 3.64
- MACD
- CC 0.06
- PRCT 0.19
- Stochastic Oscillator
- CC 45.93
- PRCT 49.48
About CC Chemours Company (The)
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.